Vanguard Total Stock Market ETF (VTI)
336.65
+0.64 (0.19%)
NYSE · Last Trade: Feb 14th, 6:34 AM EST
Detailed Quote
| Previous Close | 336.01 |
|---|---|
| Open | 336.61 |
| Day's Range | 334.27 - 338.98 |
| 52 Week Range | 236.42 - 344.42 |
| Volume | 8,039,419 |
| Market Cap | 5.54B |
| Dividend & Yield | 3.804 (1.13%) |
| 1 Month Average Volume | 7,261,285 |
Chart
News & Press Releases
Retail investors are now looking forward to a full approval of Anktiva in the EU for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ.
Via Stocktwits · February 13, 2026
According to a report from the Wall Street Journal from Friday, the cuts will help the company focus on its store employees.
Via Stocktwits · February 13, 2026
The company said that the decision to layoff 64% of its workforce was approved by its board of directions on Feb. 9.
Via Stocktwits · February 13, 2026
The FDA said in a letter to the company published on Friday that the data submitted by the company is insufficient proof of clinical benefit for bitopertin.
Via Stocktwits · February 13, 2026
Rivian Stock Soars After Hours On Upbeat Guidance Stoked By Upcoming R2 Launchstocktwits.com
Via Stocktwits · February 12, 2026
INMB Stock Rises Pre-Market – What Did The FDA Say About Its Alzheimer’s Trial?stocktwits.com
Via Stocktwits · February 12, 2026
APP Stock Slumps After-Hours Despite Strong Q4 Earnings — Why Does Retail See This As A Buying Opportunity?stocktwits.com
Via Stocktwits · February 11, 2026
Starting Sunday, users can only subscribe to full self-driving technology for $99/ month.
Via Stocktwits · February 13, 2026
The company said it expects Q1 2026 total net revenue of $1.200 billion, up roughly 18% from a year ago.
Via Stocktwits · February 13, 2026
Lockheed Martin shares have rallied heavily this year, boosted by missile contracts and strong earnings.
Via Stocktwits · February 13, 2026
Ultragenyx said on Thursday that the FDA has again refused approval for UX111 in the treatment of Sanfilippo syndrome type A.
Via Stocktwits · February 13, 2026
Amazon.com stock has lost about 17.5% of its value in the last one month, even as the company’s shares hover near their lowest level since May 23, 2025.
Via Stocktwits · February 13, 2026
The company announced pricing for a $12 million public offering at an 8% discount to Thursday’s close.
Via Stocktwits · February 13, 2026
Pinterest reported earnings per share of $0.67 on revenue of $1.32 billion, compared to Wall Street estimates of an EPS of $0.67 on revenue of $1.33 billion.
Via Stocktwits · February 13, 2026
Citi lowered the firm's price target on Snapchat's parent company to $6 from $10 and kept a ‘Neutral’ rating on the shares.
Via Stocktwits · February 12, 2026
Applied Materials forecast revenues for Q2 at about $7.65 billion, beating analyst expectations of $7.02 billion on average, as per Fiscal.ai data.
Via Stocktwits · February 12, 2026
Jim Chanos, the founder of Kynikos Associates said in an X post on Thursday that IBM is essentially a marketing and consulting company, not a cutting-edge AI company.
Via Stocktwits · February 12, 2026
H.C. Wainwright raised the firm's price target on Novocure to $47 from $39 and kept a ‘Buy’ rating on the shares after the company announced FDA approval of Optune Pax.
Via Stocktwits · February 12, 2026
DraftKings said it is expecting fiscal year 2026 revenue to be in the range of $6.5 billion to $6.9 billion, compared to analysts’ estimates of $7.3 billion, as per data from fiscal.ai.
Via Stocktwits · February 12, 2026
Coinbase said that crypto is cyclical, and that it is well-capitalized to weather these cycles, with $11.3 billion in cash and cash equivalents.
Via Stocktwits · February 12, 2026
UBS, Citi and JPMorgan revised their price targets on the stock on the heels of the company issuing fresh guidance for fiscal 2026.
Via Stocktwits · February 12, 2026
Monness Crespi analyst has downgraded the Coinbase stock to ‘Sell’ from ‘Buy’ and said it is “again” cutting its estimates for Coinbase's Q4 earnings.
Via Stocktwits · February 12, 2026
Randy Teel has been appointed as President, CEO, as well as a member of the Company’s Board of Directors, effective immediately.
Via Stocktwits · February 12, 2026
The company shared optimistic timelines for advancing the clinical studies of both oral and subcutaneous VK2735 in obesity.
Via Stocktwits · February 11, 2026
The company said it intends to use the net proceeds from the notes offering for general corporate purposes.
Via Stocktwits · February 11, 2026
